Reserpine induces vascular α2‐adrenergic supersensitivity and platelet α2‐adrenoceptor up‐regulation in dog
Open Access
- 30 September 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 101 (2) , 329-336
- https://doi.org/10.1111/j.1476-5381.1990.tb12710.x
Abstract
1 The aim of the present study was to investigate the influence of catecholamine levels on the regulation of α2-adrenoceptor sensitivity in dogs. 2 Blood pressure and heart rate values at rest, plasma catecholamine levels, platelet and adipocyte α2-adrenoceptors as well as the α2-mediated cardiovascular responses to clonidine (10 μg kg−1 i.v., after α1-, β-adrenoceptor plus muscarinic blockade) or noradrenaline (0.5, 1, 2 and 4 μg kg−1 i.v. after α1- and β-adrenoceptor blockade) were measured before and after reserpine treatment (0.1 mg kg−1 day−1 s.c. over 15 days). 3 Reserpine induced a significant decrease in resting systolic and diastolic blood pressures (213 ± 2/87 ± 6 mmHg before vs 158 ± 5/59 ± 3mmHg after treatment) as well as in heart rate (91 ± 2 beats min−1 before vs 76 ± 3 beats min−1 after treatment). 4 A 5 min tilt test performed under chloralose anesthesia, failed to modify blood pressure before treatment whereas it induced a significant fall in the same animals after the 15 day treatment. Plasma levels of noradrenaline significantly decreased (262 ± 58 vs 66 ± 31 pg ml−1) whereas plasma adrenaline levels were unchanged. 5 The α2-mediated pressor responses to noradrenaline were significantly increased after reserpine. Clonidine induced a marked pressor effect (+72 and +45% in systolic and diastolic blood pressures respectively) after reserpine treatment. This effect was suppressed by administration of RX-821002, a new specific α2-adrenoceptor antagonist. 6 Reserpine treatment significantly increased platelet α2-adrenoceptor number (identified with [3H]-yohimbine or [3H]-RX821002) with no change in Kd values. α2-Adrenoceptor number remained unchanged in adipocytes (identified with [3H]-RX821002). 7 These results show that a 15 day treatment with reserpine induces a vascular α2-adrenergic supersensitivity and an up-regulation in platelet α2-adrenoceptors. In contrast, this phenomenon does not involve all the tissues since adipocyte α2-adrenoceptors escape the effect of reserpine. We suggest that the levels of plasma noradrenaline play an important role in the regulation of the platelet and vascular α2-adrenoceptors. In contrast, adipocyte α2-adrenoceptors are not affected by changes in plasma noradrenaline levels.This publication has 42 references indexed in Scilit:
- Rilmenidine (S 3341) and the sympathoadrenal system: adrenoreceptors, plasma and adrenal catecholamines in dogsJournal of Autonomic Pharmacology, 1988
- The Effects of Chronic Administration of Adrenaline on the Function and Number of Adrenoceptors in the RabbitJournal of Cardiovascular Pharmacology, 1988
- Metabolism of Alpha-And Beta-Adrenergic Receptors In Vitro and In VivoAnnual Review of Pharmacology and Toxicology, 1987
- Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: assessment by analysis of beta and alpha2 adrenoceptors propertiesEuropean Journal of Clinical Investigation, 1985
- Reserpine-induced changes in cardiac adrenergic receptorsCanadian Journal of Physiology and Pharmacology, 1984
- Influence of sympathectomy on alpha2 adreboceptor binding sites in canine blood vesselsLife Sciences, 1983
- Endogenous and Exogenous Regulation of Human α- and β-Adrenergic ReceptorsJournal of Receptor Research, 1983
- MINI‐REVIEW THE POSTSYNAPTIC α2‐ADRENORECEPTORJournal of Autonomic Pharmacology, 1981
- α2-Adrenergic receptors appear in rat salivary glands after reserpine treatmentNature, 1980
- The recovery of noradrenaline in adrenergic nerve terminals of the rat after reserpine treatmentJournal of Pharmacy and Pharmacology, 1971